| Herman Ronald Clements Ii, MD | |
|
403 S Poplar St, Suite C, Searcy, AR 72143-6017 | |
| (501) 279-7600 | |
| (501) 279-7605 |
| Full Name | Herman Ronald Clements Ii |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 32 Years |
| Location | 403 S Poplar St, Searcy, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427019371 | NPI | - | NPPES |
| E5550 | Other | AR | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | G87251 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | E5550 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White County Medical Center | Searcy, AR | Hospital |
| Conway Regional Health System | Conway, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Conway Regional Medical Center Inc | 3173428414 | 127 |
| Hometown Behavioral Health Services Of Arkansas, Inc | 4183779226 | 10 |
| White County Medical Center | 4880688654 | 149 |
News Archive
A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers at the Robert N. Butler Columbia Aging Center at Columbia University Mailman School of Public Health found that mortality among those with hearing loss is elevated, particularly among men and women younger than age 75 and those who are divorced or separated.
Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
Patches seem to be all the rage these days. There are birth control patches, nicotine patches, and transdermal medicinal patches, just to name a few.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
› Verified 7 days ago
| Entity Name | Hometown Behavioral Health Services Of Arkansas, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629226931 PECOS PAC ID: 4183779226 Enrollment ID: O20090826000169 |
News Archive
A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers at the Robert N. Butler Columbia Aging Center at Columbia University Mailman School of Public Health found that mortality among those with hearing loss is elevated, particularly among men and women younger than age 75 and those who are divorced or separated.
Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
Patches seem to be all the rage these days. There are birth control patches, nicotine patches, and transdermal medicinal patches, just to name a few.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
› Verified 7 days ago
| Entity Name | White County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053662890 PECOS PAC ID: 4880688654 Enrollment ID: O20130510000018 |
News Archive
A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers at the Robert N. Butler Columbia Aging Center at Columbia University Mailman School of Public Health found that mortality among those with hearing loss is elevated, particularly among men and women younger than age 75 and those who are divorced or separated.
Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
Patches seem to be all the rage these days. There are birth control patches, nicotine patches, and transdermal medicinal patches, just to name a few.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
› Verified 7 days ago
| Entity Name | Conway Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730402249 PECOS PAC ID: 3173428414 Enrollment ID: O20200527001733 |
News Archive
A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers at the Robert N. Butler Columbia Aging Center at Columbia University Mailman School of Public Health found that mortality among those with hearing loss is elevated, particularly among men and women younger than age 75 and those who are divorced or separated.
Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
Patches seem to be all the rage these days. There are birth control patches, nicotine patches, and transdermal medicinal patches, just to name a few.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Herman Ronald Clements Ii, MD 403 S Poplar St, Suite C, Searcy, AR 72143-6017 Ph: (501) 279-7600 | Herman Ronald Clements Ii, MD 403 S Poplar St, Suite C, Searcy, AR 72143-6017 Ph: (501) 279-7600 |
News Archive
A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers at the Robert N. Butler Columbia Aging Center at Columbia University Mailman School of Public Health found that mortality among those with hearing loss is elevated, particularly among men and women younger than age 75 and those who are divorced or separated.
Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.
The U.S. government continues to lay the groundwork for efforts under the U.S. Global Health Initiative (GHI), announcing the first round of "GHI Plus" countries, as well as the program's governance structure. GHI is a six-year, $63 billion initiative to help partner countries improve measurable health outcomes by strengthening health systems and building upon proven results. It places a particular focus on improving the health of women, newborns and children.
Patches seem to be all the rage these days. There are birth control patches, nicotine patches, and transdermal medicinal patches, just to name a few.
AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective drug candidate being developed for the treatment of Acute Ischemic Stroke. The results will be delivered as a podium presentation during the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon July 10 - 14, 2010.
› Verified 7 days ago
Pawel Krzysztof Kurylo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1120 S Main St, Searcy, AR 72143 Phone: 501-804-4680 | |
Dr. Robert Strayhan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2908 Hawkins Dr, Searcy, AR 72143 Phone: 501-203-0055 Fax: 501-203-0060 | |
Mrs. Peggy J Brown, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 609 Marion St, Searcy, AR 72143 Phone: 501-278-5610 Fax: 501-278-5614 | |
Michael E Clevenger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2800 Fax: 501-278-3073 | |
Dr. Andrew Marcus Curley, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2908 Hawkins Dr, Searcy, AR 72143 Phone: 501-203-0055 | |
Andrew Troy Hodge, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2908 Hawkins Dr, Searcy, AR 72143 Phone: 501-203-0055 |